OPTIMIZATION OF THYROID CANCER PATIENT MANAGEMENT TACTICS BASED ON PERSONALIZED TREATMENT APPROACHES

Abstract

Relevance. Thyroid cancer patient management has undergone significant changes in recent years, driven by advances in understanding tumor biology, the development of molecular genetic technologies, and the introduction of personalized medicine. Although most forms of thyroid cancer have a relatively favorable prognosis, the clinical course of the disease is significantly heterogeneous, ranging from slowly progressing, well-differentiated tumors to aggressive, radioiodine-resistant forms with a high risk of recurrence and metastasis. Therefore, choosing the optimal patient management strategy is particularly important [1,5].